Phase I Study of the Anti Insulin-Like Growth Factor 1 Receptor (IGF-1R) Monoclonal Antibody, AVE1642, as Single Agent and in Combination With Bortezomib in Patients With Relapsed Multiple Myeloma
Leukemia - United Kingdom
doi 10.1038/leu.2011.4
Full Text
Open PDFAbstract
Available in full text
Date
February 15, 2011
Authors
Publisher
Springer Science and Business Media LLC